WCN26-6146 NKG2D Signaling in Podocyte DNA Damage Drives Cardiorenal Axis and CKD Progression: A Therapeutic Strategy and Prognostic Biomarker

Read full text Summarise with VIRAT
Authors: Tomomi Maruki, Ran Nakamichi, Akinori Hashiguchi, Jin Komuro, Akito Hishikawa, Erina Sugita Nishimura, Eriko Yoshida Hama, Wataru Ito, Seiei Iwabuchi, Ryuto Yoshida, Masataro Toda, Rina Takahashi
+3 more Takeshi Kanda, Masaki Ieda, Kaori Hayashi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

We elucidated the mechanism by which DNA damage induces NKG2D ligand expression, activating NKG2D+CD8+T cells, thereby exacerbating proteinuria and kidney damage, using mice with podocyte-specific expression of I-PpoI, a homing endonuclease inducing non-mutagenic DNA double-strand breaks (DSBs) (Cell rep 2023). However, systemic effects of the NKG2D+CD8+T cell activation have not been elucidated. In this study, we aim to determine the therapeutic effect of NKG2D signal blockade on both CKD progression and cardiac function in clinically relevant kidney disease models, such as diabetes and nephrotic syndrome.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Chronic Kidney Disease and Diabetes Immune Cell Function and Interaction

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104492–104492
Publication date
25 March 2026
Language
EN